Dutton H, Borengasser SJ, Gaudet LM, Barbour LA, Keely EJ
Lauschke y otros investigadores del Instituto Karolinska, la Universidad de Estocolmo y la Universidad de Uppsala (Suecia), la Universidad de Copenhague (Dinamarca), y la Universidad de Monash y la Universidad de Queensland (Australia)
Remdesivir has been shown to exhibit pan-coronavirus inhibitory potential 10 , and has been granted approval by the US Food and Drug Administration (FDA) for the treatment of COVID-19 on the basis of the reduced time taken to recover following treatment with this drug 11
Esasen, bir organizmann endokrin ilevselliini ynetir
Drug-induced neuropathy requires G62.0 + an adverse effect T-code, not G62.9 alone
Treatment plans are customized by the prescribing provider based on the patients individual needs